MedPath

A effect of classical Ayurvedic treatments in patients with Psoriatic Arthritis

Not Applicable
Completed
Conditions
Health Condition 1: null- Psoriatic Arthritis
Registration Number
CTRI/2018/09/015820
Lead Sponsor
AYUSH GOVERNMENT of INDIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Age between 18 to 60 years,

2.Either sex,

3.Psoriasis associated with arthritic symptoms. 4.History of Psoriasis,

5.Morning stiffness/ Stiffness of Joints,

Arthritis of Three or more joints/ Arthritis of smaller joints/ Spondylitis.

6.Anyone of these symptoms- Silvery scaling, circular patches, Itching/ nail changes.

7.Any one of these Positive signs- Kobenerâ??s phenomenon, Candle grease sign and Auspitâ??z sign.

Exclusion Criteria

1.Age less than 18 years and above 60 years,

2.Patients having other debilitating disease / Unable to walk without support/ severe structural deformity.

3.Patients on Steroids Medicines.

4.Patients who develop secondary complication e.g. pleuro- pericardial disease, severely damaged joint with bed ridden patients.

5.Other Arthritis like Gout, Osteo-arthritis, Tubercular arthritis, Rheumatic Fever, Gonorrheal arthritis/ syphilitic arthritis, Arthritis with malignancy, Acute pyogenic arthritis, Rheumatoid arthritis, Osteomyelitis, Ankylosing spondylitis,

6.Patients with poorly controlled Hypertension/ Diabetes Mellitus/ Hepatic disorder/ Alcoholic/ Drug Abuser.

7.Having Cardiac disease/ Failure, Pulmonary Tuberculosis, Pregnant women/ lactating women etc.

Hypersensitivity to any of the trail drugs

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate The Efficacy Of Classical Ayurvedic Treatment In Psoriatic ArthritisTimepoint: 1.5yrs
Secondary Outcome Measures
NameTimeMethod
TO ESTABLISH THE SAFETY OF AYURVEDIC LINE OF MANAGEMENT IN RHEUMATOID ARTHRITISTimepoint: ONE AND HALF YEAR
© Copyright 2025. All Rights Reserved by MedPath